Angiotensin-converting enzyme inhibitors are not effective at inhibiting further fibrous changes in the atria in patients with chronic atrial fibrillation. Speculation from analysis of the time course of fibrillatory wave amplitudes

Japanese Heart Journal

Volumn 45, Issue 1, 2004, Pages 93-101

  Hirayama, Yoshiyuki ^a   Atarashi, Hirotsugu ^a   Kobayashi, Yoshinori ^a   Takano, Teruo ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Angiotenin converting enzyme inhibitor; Atrial fibrillation; Fibrosis

Indexed keywords

BISOPROLOL; CAPTOPRIL; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; METILDIGOXIN; METOPROLOL; PROPRANOLOL; VERAPAMIL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFICACY; ELECTROCARDIOGRAM; ELECTRODE; FEMALE; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HEART MUSCLE FIBROSIS; HUMAN; MALE; MEDICAL RECORD; PATIENT CODING; PRIORITY JOURNAL; CHRONIC DISEASE; CLINICAL TRIAL; ELECTROCARDIOGRAPHY; FIBROSIS; HYPERTENSION; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; VALVULAR HEART DISEASE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ATRIAL FIBRILLATION; CHRONIC DISEASE; ELECTROCARDIOGRAPHY; FEMALE; FIBROSIS; HEART ATRIA; HEART VALVE DISEASES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 1642485749     PISSN: 00214868     EISSN: 1348673X     Source Type: Journal    
DOI: 10.1536/jhj.45.93     Document Type: Article

References (24)

1. Fortuno MA, Ravassa S, Etayo, Diez J. Overexpression of Bax protein and enhanced apoptosis in the left ventricle of spontaneously hypertensive rats: effects of AT1 blockade with losartan. Hypertension 1998; 32: 280-6.
2. Pedersen OD, Bagger H, Kober L, Pedersen CT. Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction. Circulation 1999; 100: 376-80.
3. Morillo CA, Klein GJ, Jones DL, Guiraudon CM. Chronic rapid atrial pacing: structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation 1995; 91: 1588-95.
4. Ausma J, Wijffels M, Thone F, Wouter SL, Allesie M, Borgers M. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation 1997; 96: 3157-63.
5. Nakashima H, Kumagai K, Urata H, Gondo N, Ideishi M, Arakawa K. Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation. Circulation 2000; 101: 2612-7.
6. Li D, Shinagawa K, Pang L, et al. Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure. Circulation 2001; 104: 2608-14.
7. Lie JT, Falk RH, James TN. Cardiac anatomy and pathologic correlates of atrial fibrillation. In: Falk RH, Podrid PJ, editor. Atrial Fibrillation: Mechanisms and Management, 2nd ed. Philadelphia: Lippincott-Raven; 1997: 23-52.
8. Li YH, Hwang JJ, Tseng YZ, Kuan P, Lien WP. Clinical significance of fibrillatory wave amplitude: A clue to left atrial appendage function in nonrheumatic atrial fibrillation. Chest 1995; 108: 359-63.
9. Skoulas, A. Horlick L. The atrial F wave in various types of heart disease and its response to treatment. Am J Cardiol 1964; 14: 174-7.
10. Morganroth J, Horowitz LN, Josephson ME, Kastor JA. Relationship of atrial fibrillatory wave amplitude to left atrial size and etiology of heart disease. Am Heart J 1979; 97: 184-6.
11. Aysha MH, Hassan AS. Diagnostic importance of fibrillatory wave amplitude: A clue to echocardiographic left atrial size and etiology of atrial fibrillation. J Electrocardiology 1988; 21: 247-51.
12. Thurmann M, Janney J. The diagnostic importance of fibrillatory wave size. Circulation 1962; 25: 991-4.
13. Sopher SM, Camm AJ. Atrial fibrillation - maintenance of sinus rhythm versus rate control. Am J Cardiol 1996; 77: 24A-38A.
14. Rocken C, Peters B, Juenemann G, et al. Atrial amyloidosis. An arrhythmogenic substrate for persistent atrial fibrillation. Circulation 2002; 106: 2091-7.
15. Kohl P, Noble D. Mechanosensitive connective tissue: potential influence on heart rhythm. Cardiovasc Res 1996; 32: 62-8.
16. Boutjdir M, Le Heuzey JY, Lavergne T. Inhomogeneity of cellular refractoriness in human atrium: factor of arrhythmia? PACE 1986; 9: 1095-100.
17. Nakagawa K, Hirai T, Shinokawa N, et al. Relation of fibrillatory wave amplitude with hemostatic abnormality and left atrial appendage dysfunction in patients with chronic nonrheumatic atrial fibrillation. Jpn Circ J 2001; 65: 375-80.
18. Sekiguchi M, Nishino H, Nishikawa T, Morimoto S, Hiroe M. Age-associated myocardial changes in various heart diseases. A clinicopathologic analysis in biopsied and autopsied myocardium. Jpn Circ J 1986; 50: 1023-32.
19. Noble RJ, Fisch C. Factors in the genesis of atrial fibrillation in rheumatic valvular disease. Cardiovasc Clin 1972; 5: 97-114.
20. Thiedemann KU, Ferrans VJ. Left atrial ultrastructure in mitral valvular disease. Am J Pathol 1977; 89: 575-604.
21. Unverferth DV, Fertel RH, Unverferth BJ, Leier CV. Atrial fibrillation in mitral stenosis: histologic, hemodynamic and metabolic factors. Int J Cardiol 1984; 1: 143-54.
22. Goette A, Lendeckel U, Klein HU. Signal transduction systems and atrial fibrillation. Cardiovasc Res 2002; 54: 247-58.
23. Goette A, Staack T, Rocken C, et al. Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. J Am Coll Cardiol 2000; 35: 1669-77.
24. Blackshear JL, Safford RE, Pearce LA, on behalf of the Stroke Prevention in Atrial Fibrillation Investigators. Famplitude, left atrial appendage velocity, and thromboembolic risk in nonrheumatic atrial fibrillation. Clinical Cardiol 1996; 19: 309-13.